GTC BIOTHERA (NASDAQ:GTCB)

1.10

+0.02 (1.85%)

GTC BIOTHERA (NASDAQ:GTCB) Delayed :
Previous Close	$1.08	52 Week High	$2.70
Open	$1.07	52 Week Low	$0.11
Day High	$1.10	P/E	N/A
Day Low	$1.05	EPS	$-0.14
Volume	14,874
More GTCB Info: Chart SEC Filings Profile Historical Options

Entities who have mentioned GTCB

View All Entities

Nov 2, 2009 09:25 AM LFB Biotech Exercise Option to purchase $12.80M in Additional Convertible Shares of Preferred from GTC Biothera (GTCB)
May 26, 2009 04:50 PM GTC Biotherapeutics (GTCB) Files For 1-to-10 Reverse Stock Split
May 13, 2009 09:32 AM GTC Biotherapeutics (GTCB) Reports Q1 Loss of $0.10
May 12, 2009 03:09 PM GTC Biotherapeutics (GTCB) Regains Nasdaq Compliance
Mar 9, 2009 08:29 AM GTC Biotherapeutics (GTCB) Reports Progress in ATryn Program in U.S.

Nov 19, 2009 08:00AM GTC Biotherapeutics Receives Extension to Regain Compliance with NASDAQ Listing Standards
Nov 6, 2009 08:00AM GTC Biotherapeutics Reports Third Quarter 2009 Financial Results
Nov 2, 2009 04:31PM GTC Biotherapeutics to Host Third Quarter 2009 Earnings Call on November 6, 2009 and Webcast the Merriman Investor Summit Presentation on November 10, 2009
Nov 2, 2009 08:40AM LFB Provides $10 Million of Funding To GTC Biotherapeutics
Oct 5, 2009 04:45PM GTC Biotherapeutics Announces Changes in Board

Sep 23, 2008 05:10 PM GTC Biotherapeutics, Inc. Q2 2008 Earnings Call Transcript

Nov 19, 2009 09:25AM Form 8-K GTC BIOTHERAPEUTICS INC For: Nov 18
Nov 6, 2009 04:57PM Form 8-K GTC BIOTHERAPEUTICS INC For: Nov 05
Nov 6, 2009 03:58PM Form 10-Q GTC BIOTHERAPEUTICS INC For: Sep 27
Nov 6, 2009 09:10AM Form 8-K GTC BIOTHERAPEUTICS INC For: Nov 06
Nov 5, 2009 04:02PM Form SC 13D/A GTC BIOTHERAPEUTICS INC Filed by: LFB Biotechnologies S.A.S.U.

Dan Gillespie
on Feb 20, 2008
at 03:42 PM INSM A $3.00 dollar stock trading below a $1.00.
Article: Analyst Call of the Year: Collins Stewart on Encysive (ENCY)

No comments are currently available.